This Week at the FDA: Multiple Myeloma and Mobile Apps

Happy Friday!

Winter is coming and so is FDA news! Take a moment to check out some recent FDA announcements.

FDA Approves Triplet Immunotherapy Combination for Multiple Myeloma

Big news for people with multiple myeloma! A new immunotherapy was just approved for adults who had received two or more treatments before, including lenalidomideand a proteasome inhibitor.

FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data

How can phones change the way researchers look at data? The FDA is working on finding out.

FDA grants selinexor Fast Track Designation for the treatment of patients with DLBCL

The lymphoma community just got some good news– the FDA is fast-tracking a potential treatment.

MMJ International Holdings Files Huntington’s Disease FDA Orphan Drug Application

Huntington’s disease has limited treatment options, but many are hoping that this is the first step towards better options.

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email